As California ends Medicaid coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, experts say the state's advice to ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

As the popularity of weight-loss drugs continues to boom, it has opened the door for scammers eager to dupe people into ...

New analysis adds to existing evidence that Omada’s program paired with GLP-1 medications leads to greater weight loss and persistence than reported in real world evidenceSAN FRANCISCO, Jan. 08, 2026 ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

State health plan overseers are pushing back against potential plan design changes that would shift more costs onto enrollees, particularly a staff recommendation to help close a large budget gap by ...

A large review found that people who stopped taking GLP-1 drugs regained weight nearly twice as fast as people who gave up ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend ...

The weight-loss drug Wegovy is now being sold in pill form, an advancement that allows users to transition away from weekly injections. It's the first GLP-1 weight-loss medication to become available ...

When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop covering blockbuster obesity drugs Zepbound and Wegovy next year, it pointed them to an ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...